| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef2a6d661df17e57ad3155c24188735 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate |
1999-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19e755f026e9043b35832f48104fc9e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_815e04125805d203591311039a1f6dc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb111f8870cc39b61a40aba74f47e2af |
| publicationDate |
2001-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2001172183-A |
| titleOfInvention |
Ophthalmic pharmaceutical composition |
| abstract |
PROBLEM TO BE SOLVED: To provide an ophthalmic pharmaceutical composition having an excellent anti-inflammatory action. SOLUTION: An ophthalmic pharmaceutical composition containing lornoxicam as an active ingredient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8920820-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10098891-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4524538-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9993485-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03075920-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016113456-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10548901-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003300871-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012529504-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1307992-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005511720-A |
| priorityDate |
1999-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |